Identification of a CSR specific checkpoint

识别 CSR 特定检查点

基本信息

  • 批准号:
    10198743
  • 负责人:
  • 金额:
    $ 19.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-19 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Humoral immune responses require the diversification of the Ig repertoire by means of antigen receptor rearrangements. The mouse Igh locus spans 2.9 Mb within which are ~100 functional VH gene segments that participate in V(D)J recombination and eight CH genes that are used during class switch recombination (CSR). Activation induced deaminase (AID) is essential for both immunoglobulin somatic hypermutation and CSR in mature B cells. CSR requires transcription and induction of DNA double strand breaks (DSBs) that must synapse over long genomic distances to facilitate intra-chromosomal rearrangement. The Igh locus assumes specific chromatin topologies that facilitate CSR and these may vary at different stages of B cell development. In new studies we have examined the relationship between developmentally regulated higher-order chromatin structure, gene expression and recombination using chromosome conformation capture based approaches in combination with functional assessment of CSR. We discovered an unexpectedly high frequency of chromatin interactions among downstream CH genes. This led us to postulate that downstream S regions could recombine with each other. Our studies confirmed this hypothesis and led to a revision of the model for CSR. These studies stimulated us to search for B cell subsets that are actively engaged in CSR. Unexpectedly, B cells that are engaged in CSR become BCR negative and reside in the G1 phase of the cell cycle suggesting the presence of a DNA double strand break checkpoint. Furthermore, BCR- cells dynamically transition to IgM+ and then re-cycle to BCR-. Here we propose to profile the transcriptome of B cell subsets engaged in CSR and determine their cell fate branch point. These studies are very important since BCR negative B cells will be unresponsive to exogenous antigen and this has important implications for B cell activation.
摘要

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Loop extrusion promotes an alternate pathway for isotype switching.
  • DOI:
    10.1016/j.celrep.2021.110059
  • 发表时间:
    2021-11-23
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Shen HM;Wuerffel R;Cantillo JF;Priyadarshi S;Lei X;Liang J;Wu YL;Kenter AL
  • 通讯作者:
    Kenter AL
Igh Locus Polymorphism May Dictate Topological Chromatin Conformation and V Gene Usage in the Ig Repertoire.
  • DOI:
    10.3389/fimmu.2021.682589
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Kenter AL;Watson CT;Spille JH
  • 通讯作者:
    Spille JH
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Amy L Kenter其他文献

Amy L Kenter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Amy L Kenter', 18)}}的其他基金

Impact of novel enhancers on Igh repertoire diversity
新型增强子对 Igh 库多样性的影响
  • 批准号:
    10716628
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
Igh locus function in immunosenescent mice
免疫衰老小鼠中的 Igh 基因座功能
  • 批准号:
    10303603
  • 财政年份:
    2021
  • 资助金额:
    $ 19.99万
  • 项目类别:
Igh locus function in immunosenescent mice
免疫衰老小鼠中的 Igh 基因座功能
  • 批准号:
    10427437
  • 财政年份:
    2021
  • 资助金额:
    $ 19.99万
  • 项目类别:
Identification of a CSR specific checkpoint
识别 CSR 特定检查点
  • 批准号:
    10063761
  • 财政年份:
    2020
  • 资助金额:
    $ 19.99万
  • 项目类别:
Characterization of chromatin loops responsible for Igh locus contraction
负责 Igh 基因座收缩的染色质环的表征
  • 批准号:
    8873312
  • 财政年份:
    2015
  • 资助金额:
    $ 19.99万
  • 项目类别:
Role of MBD4 in double strand break formation during class switch recombination
MBD4 在类别转换重组过程中双链断裂形成中的作用
  • 批准号:
    8702378
  • 财政年份:
    2014
  • 资助金额:
    $ 19.99万
  • 项目类别:
Class switch recombination during early B cell development
早期 B 细胞发育过程中的类别转换重组
  • 批准号:
    8594576
  • 财政年份:
    2013
  • 资助金额:
    $ 19.99万
  • 项目类别:
Class switch recombination during early B cell development
早期 B 细胞发育过程中的类别转换重组
  • 批准号:
    8664344
  • 财政年份:
    2013
  • 资助金额:
    $ 19.99万
  • 项目类别:
Lymphocytes/Immune System:Cellular/Interactive Mechanism
淋巴细胞/免疫系统:细胞/相互作用机制
  • 批准号:
    7000871
  • 财政年份:
    2005
  • 资助金额:
    $ 19.99万
  • 项目类别:
Factors and DNA Motifs Involved in Ig Class Switch
参与 Ig 类别转换的因素和 DNA 基序
  • 批准号:
    6629967
  • 财政年份:
    2003
  • 资助金额:
    $ 19.99万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 19.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了